HomeCompareFLXI vs MRK

FLXI vs MRK: Dividend Comparison 2026

FLXI yields 0.43% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $38.0K in total portfolio value
10 years
FLXI
FLXI
● Live price
0.43%
Share price
$48.27
Annual div
$0.21
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.7K
Annual income
$0.04
Full FLXI calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — FLXI vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFLXIMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FLXI + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FLXI pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FLXI
Annual income on $10K today (after 15% tax)
$36.44/yr
After 10yr DRIP, annual income (after tax)
$0.03/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MRK beats the other by $8,596.68/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FLXI + MRK for your $10,000?

FLXI: 50%MRK: 50%
100% MRK50/50100% FLXI
Portfolio after 10yr
$38.7K
Annual income
$5,056.91/yr
Blended yield
13.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FLXI
No analyst data
Altman Z
31.0
Piotroski
7/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FLXI buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFLXIMRK
Forward yield0.43%2.81%
Annual dividend / share$0.21$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$19.7K$57.7K
Annual income after 10y$0.04$10,113.78
Total dividends collected$43.00$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FLXI vs MRK ($10,000, DRIP)

YearFLXI PortfolioFLXI Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,721$21.43$11,213$373.04$492.00MRK
2$11,483$10.74$12,667$512.06$1.2KMRK
3$12,292$5.37$14,439$708.14$2.1KMRK
4$13,155$2.69$16,640$988.16$3.5KMRK
5$14,077$1.34$19,432$1,394.07$5.4KMRK
6$15,063$0.67$23,057$1,992.90$8.0KMRK
7$16,118$0.34$27,889$2,894.79$11.8KMRK
8$17,246$0.17$34,518$4,286.29$17.3KMRK
9$18,454$0.08$43,912$6,494.35$25.5KMRK
10$19,746$0.04$57,714$10,113.78$38.0KMRK

FLXI vs MRK: Complete Analysis 2026

FLXIStock

FlexiInternational Software Inc. develops, markets, and supports back office accounting software solutions for companies in banking and credit union, insurance, financial services, and other service industries worldwide. The company offers offers FlexiFinancials suite that consists of FlexiLedger, a core repository of financial transactions; FlexiPayables, an accounts payable module; FlexiPurchasing to track and streamline the purchasing processes; FlexiAssets, a fixed assets module; FlexiProjects that manages, tracks, and analyzes project costs, budgets, encumbrances, and status; FlexiFDW, an event-driven data repository; and FlexiReceivables for companies to manage and track their receivables. It also provides FlexiTools applications to customize FlexiFinancials, such as FlexiDesigner to customize the FlexiFinancials Suite GUI using an interactive visual design editor; and FlexiDB that allows the customization of the Flexi database structures. In addition, the company offers FlexiInfo Suite that consist of FlexiWorkflow, an application that is integrated with various FlexiFinancial modules; FlexiImaging that provides integration with various third party imaging solutions, including Microsoft SharePoint; and RenovoFYI, a Web based financial report writer. Further, it provides FlexiIntegration suite that consists of FlexiAPIs that provide real-time, synchronous access to functional components within the FlexiFinancials Suite of applications; FlexiNetExchange to provide a seamless integration with Jack Henry's Silverlake core banking solution, Synergy Workflow, and Synergy Imaging; and FlexiImport/Export Wizard that allow users to import and export data. Furthermore, the company offers consulting, training and education, and support services. It has strategic partnerships with Acturis; and Jack Henry & Associates. The company was founded in 1991 and is based in Shelton, Connecticut with additional locations in Naples, Florida; and Surrey, United Kingdom.

Full FLXI Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this FLXI vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FLXI vs SCHDFLXI vs JEPIFLXI vs OFLXI vs KOFLXI vs MAINFLXI vs JNJFLXI vs ABBVFLXI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.